These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32484112)

  • 21. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
    Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
    Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
    Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M
    Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of prostate-specific antigen and technetium-99m HMDP bone imaging.
    Shih WJ; Wierzbinski B; Collins J; Pearson TC; Magoun S; Ryo UY
    Clin Nucl Med; 1989 Oct; 14(10):750-5. PubMed ID: 2478331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL; Rudd TG
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot.
    Unal SN; Birinci H; Baktiroğlu S; Cantez S
    Clin Nucl Med; 2001 Dec; 26(12):1016-21. PubMed ID: 11711704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S; Liehn JC; Desoize B; Larbre H; Deltour G; Valeyre J
    Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
    Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
    Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CT flare response of metastatic bone disease in prostate cancer.
    Messiou C; Cook G; Reid AH; Attard G; Dearnaley D; de Bono JS; de Souza NM
    Acta Radiol; 2011 Jun; 52(5):557-61. PubMed ID: 21498309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
    Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
    Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
    Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
    Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
    [No Abstract]   [Full Text] [Related]  

  • 33. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study.
    Lin Y; Mao Q; Chen B; Wang L; Liu B; Zheng X; Xie L
    BMC Urol; 2017 Jun; 17(1):41. PubMed ID: 28606069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technetium 99m-MDP scintigraphy of patients undergoing implant prosthetic procedures: a follow-up study.
    Meidan Z; Weisman S; Baron J; Binderman I
    J Periodontol; 1994 Apr; 65(4):330-5. PubMed ID: 8195977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
    Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
    Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
    Ichikawa H; Shibutani T; Onoguchi M; Taniguchi Y
    Ann Nucl Med; 2022 Nov; 36(11):941-950. PubMed ID: 36048347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.
    Sabbatini P; Larson SM; Kremer A; Zhang ZF; Sun M; Yeung H; Imbriaco M; Horak I; Conolly M; Ding C; Ouyang P; Kelly WK; Scher HI
    J Clin Oncol; 1999 Mar; 17(3):948-57. PubMed ID: 10071289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.
    Chen CY; Wu K; Lin WH; Lan TY; Wang SY; Sun JS; Weng PW; Yen RF; Yang RS
    J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.